Need a specific person's email?
Browse Pluristyx, Inc.'s employee directory (about 19 employees) and reveal verified emails free.
Pluristyx, Inc.'s most common email format is First.Last@pluristyx.com (ex. John.Doe@pluristyx.com), used for 84% of pluristyx.com addresses. Pluristyx, Inc. uses 3 email patterns.
| Format | Example | Share of pluristyx.com |
|---|---|---|
| First.Last@pluristyx.comMost common | John.Doe@pluristyx.com | |
| First@pluristyx.com | John@pluristyx.com | |
| FLast@pluristyx.com | JDoe@pluristyx.com |
Browse Pluristyx, Inc.'s employee directory (about 19 employees) and reveal verified emails free.
Biotechnology ResearchWashington, United States11-50 Employees
Pluristyx, Inc. is a biotechnology research company headquartered in Seattle, Washington, with 11-50 employees and operating from two North American sites. It provides iPSC-based products and services to support early-stage product development. In July 2023, Pluristyx merged with panCELLa, combining stem cell research and gene-editing capabilities to form an expanded platform. The merged entity aims to become a global provider of clinical-grade, genetically modified, off-the-shelf induced pluripotent stem cells, designed to accelerate progression to clinical development and commercialization. Recent activity includes a May 2026 distribution agreement with Qkine, the February 2026 PluriForm-GFP-3D Transfection Kit launch with Solesis and integration for transfection, a December 2025 collaboration with Mytos and Aspen to automate GMP manufacturing, and a November 2025 partnership with BreakthroughT1D to develop immune-cloaked, safety-switch-enabled allogeneic cell lines for Type 1 Diabetes therapies.
Most common format
First.Last@pluristyx.com
Example: John.Doe@pluristyx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.